# Effect of Metoprolol on Thalassemia Cardiomyopathy

> **NCT01863173** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 45 (actual)

## Conditions studied

- B Thalassemia

## Interventions

- **DRUG:** metoprolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01863173
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863173, "Effect of Metoprolol on Thalassemia Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01863173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*